Methodologic and clinical validation of the TIMI myocardial perfusion grade in acute myocardial infarction

C. Michael Gibson, James A de Lemos, Sabina A. Murphy, Susan J. Marble, Kent W. Dauterman, Andrew Michaels, Hal V. Barron, Elliott M. Antman

Research output: Contribution to journalArticle

23 Scopus citations

Abstract

Improved microvascular perfusion using the TIMI myocardial perfusion grade (TMPG) has been related to reduced in hospital, 30-day and 2-year mortality following thrombolytic administration. We sought to validate this measure using the more quantitative technique of digital subtraction angiography (DSA) and to correlate TMPG with ST segment resolution. DSA was used to analyze films from the LIMIT AMI acute myocardial infarction trial of front loaded r-tPA and rhuMAb CD18. Dye kinetics were also characterized using DSA in 88 arteries from patients without acute coronary syndromes in the absence of an obstructive lesion. Compared to normal patients, microvascular perfusion was reduced in acute myocardial infarction patients on DSA as demonstrated by a reduction in peak Gray (brightness) (p < 0.0001), the rate of rise in Gray/sec (p < 0.0001), the blush circumference (p < 0.0001), and the rate of growth in circumference (cm/sec) (p < 0.0001). However, while DSA perfusion was impaired overall in the setting of acute myocardial infarction, TMPG grade 3 in the setting of acute myocardial infarction did not differ from that in normal patients when studied quantitatively as shown by similar rates of growth in brightness and circumference (p = NS). ST resolution and the TMPG were significantly associated (p = 0.04). Compared to normal patients, acute myocardial infarction reduces the peak brightness of the myocardium, the rate of rise in brightness, the circumference of blush and the rate of growth in circumference as assessed using digital subtraction angiography. However, acute myocardial infarction patients with TMPG 3 had rates of growth in brightness and circumference that were nearly identical to normal patients. Thus, DSA validates that TMPG 3 is associated with normal kinetics of myocardial perfusion, and this likely accounts for the low (0.7%) 30 day mortality observed among those patients with TFG 3 and TMPG 3.

Original languageEnglish (US)
Pages (from-to)233-237
Number of pages5
JournalJournal of Thrombosis and Thrombolysis
Volume14
Issue number3
DOIs
StatePublished - Dec 1 2002

Keywords

  • Acute MI
  • TIMI flow grade
  • TIMI myocardial perfusion grade
  • Thrombolysis

ASJC Scopus subject areas

  • Hematology
  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Methodologic and clinical validation of the TIMI myocardial perfusion grade in acute myocardial infarction'. Together they form a unique fingerprint.

  • Cite this

    Gibson, C. M., de Lemos, J. A., Murphy, S. A., Marble, S. J., Dauterman, K. W., Michaels, A., Barron, H. V., & Antman, E. M. (2002). Methodologic and clinical validation of the TIMI myocardial perfusion grade in acute myocardial infarction. Journal of Thrombosis and Thrombolysis, 14(3), 233-237. https://doi.org/10.1023/A:1025004911375